In:
Clinical Management Issues, Seed SRL, Vol. 4, No. 2 ( 2010-06-15), p. 65-70
Abstract:
We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she failed to respond to hydroxyurea. When she received thalidomide, haemoglobin levels increased from 3.7 g/dl to 9 g/dl. Since then, at 22 months of follow-up, the therapy is still effective and well tolerated. The case gives the opportunity to describe the clinical use of thalidomide, and its potential in the management of beta-thalassaemia.
Type of Medium:
Online Resource
ISSN:
2283-3137
,
1973-4832
DOI:
10.7175/cmi.v4i2.531
Language:
Unknown
Publisher:
Seed SRL
Publication Date:
2010
detail.hit.zdb_id:
2744441-7
